Related Experiment Video
Updated: Dec 14, 2025
04:36
Author Spotlight: Time and Cost-Effective Fibrinogen-PAGE for Fibrinogenolytic Studies
Published on: April 19, 2024
785
Fibrinogen Diagnostics in Major Hemorrhage.
Marek Bialkower1, Gil Garnier1
1BioPRIA and Department of Chemical Engineering, Monash University, Clayton, Australia.
Critical Reviews in Analytical Chemistry
|July 21, 2020
Summary
Hypofibrinogenemia, a critical condition with low fibrinogen levels, increases hemorrhage risk. Early fibrinogen replacement can improve patient outcomes, highlighting the importance of accurate diagnostic assays and clinical protocols.
Area of Science:
- Hematology
- Clinical Pathology
- Coagulation Science
Background:
- Fibrinogen is a crucial plasma protein for hemostasis.
- Critically low fibrinogen levels (hypofibrinogenemia) elevate risks of major hemorrhage and mortality.
- Normal fibrinogen concentrations range from 2-4 g/L; diagnosis occurs below 1.5-2 g/L.
Purpose of the Study:
- To review diagnostic fibrinogen assays for hypofibrinogenemia.
- To analyze the mechanisms and limitations of these assays.
- To summarize fibrinogen's role and present current major hemorrhage protocols.
Main Methods:
- Literature review of fibrinogen assays.
- Analysis of assay scientific mechanisms and limitations.
- Review of clinical major hemorrhage protocols (MHPs).
Main Results:
- Identified various fibrinogen assays for hypofibrinogenemia diagnosis.
- Detailed the scientific principles and inherent limitations of each assay.
- Summarized the current landscape of clinical management strategies for major hemorrhage.
Conclusions:
- Accurate and timely diagnosis of hypofibrinogenemia is vital for patient management.
- Understanding assay limitations is key to appropriate clinical decision-making.
- Early fibrinogen replacement is critical for improving outcomes in coagulopathic events.
Related Concept Videos
01:16Clot Retraction and Fibrinolysis
8.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.2K
01:05Introduction to Hemostasis
12.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
12.4K
01:29Venous Thrombosis III: Interprofessional Care
189
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
189
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
160
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
160